Home › IGA Glomerulonephritis › Colorado
IGA Glomerulonephritis clinical trials in Colorado
7 studies for IGA Glomerulonephritis are looking for participants at sites in Colorado.
Cities in Colorado
A Phase 3 Blinded Study of JADE101 in Participants With Immunoglobulin A Nephropathy
- Jade Clinical Site, Arvada
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 3, 2026 · NCT07902817A Study of JADE101 in Participants With Immunoglobulin A Nephropathy
- Jade Clinical Site, Arvada
- Jade Clinical Site, Denver
RecruitingPhase 2
Ages 18 to 60 · All sexes · Updated Oct 30, 2026 · NCT07541287A Study to Assess the Effects of Zigakibart on IgA Nephropathy.
- Colorado Kidney Care Nephrology, Denver
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 21, 2026 · NCT07146906Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Iptacopan in Pediatric Patients With Primary IgAN
- Childrens Hospital Colorado, Aurora
RecruitingPhase 3
Ages 2 to 18 · All sexes · Updated Sep 9, 2026 · NCT06994845Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.
- Colorado Kidney Care Nephrology, Denver
RecruitingPhase 3
Ages 18 to 100 · All sexes · Updated Aug 17, 2026 · NCT06858319Study of WAL0921 in Patients With Glomerular Kidney Diseases
- Colorado Kidney and Vascular Care, Denver
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Aug 3, 2026 · NCT06466135Study of Ravulizumab in Pediatric Participants With Primary IgAN
- Research Site, Aurora
RecruitingPhase 3
Ages 2 to 18 · All sexes · Updated Jul 30, 2026 · NCT07024563From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.